Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Healthcare

Actinogen Medical (ASX:ACW) Shares Rise 22% as Alzheimer’s Trial Database Lock Sets Up Mid-November Readout

Actinogen locked the XanaMIA database late on 20 October 2026 and announced the milestone the next day, narrowing earlier guidance of November to mid-November for topline results. The final participant visit took place in the United States on 22 September, and the trial is …

Aditi Sarkar | 09 November 2026

How Could Biome Australia’s (ASX:BIO) China Distribution Deal Reshape Its Growth Path?

The agreement covers cross-border e-commerce only, including platforms such as Tmall Global, Douyin, PDD and RedNote. The term runs from signing, and no earlier than 1 November 2026, to 31 December 2029. Year 1 is unconditional exclusivity, which runs to 31 December 2027.

Sonal Goyal | 09 November 2026

What Does Indian Patent No. 605429 Mean for LTR Pharma’s (ASX:LTP) Intranasal Products?

The patent is titled Formulations and Methods for Treating Erectile Dysfunction and protects defined formulation characteristics relating to the company’s intranasal technology. The release does not reproduce the claims, so the precise scope of protection is not described in detail beyond the company’s general …

Sonal Goyal | 09 November 2026

Can Vitasora Health (ASX:VHL) Scale Its Care Coordinator Model After Improved Patient Results?

The poorly controlled diabetes rate fell from 13.1% at about six months to 6.7% at about 12 months, against a national benchmark of 28.1%. Blood pressure control rose from 79.6% to 82.9%, and depression screening and follow-up improved from 70.3% to 79.5%. The company …

Sonal Goyal | 09 November 2026

Ramsay Health Care (ASX:RHC) Nears an 80% Yearly Gain, Santé Reshapes Its Next Chapter

Ramsay Health Care released Ramsay Santé’s results for the three months ended 30 September 2026 on 6 November. Ramsay held 52.79% of the subsidiary. The EuropeanBusinessreported revenue of EUR1,232.9 million, increasing 2.9% year on year, or 2.6% at constant exchange rates. These areSubsidiaryfigures and …

Sonal Goyal | 08 November 2026

Epiminder (ASX:EPI) Secures Higher 2027 Medicare Hospital Payment for Minder Implant Procedure

The US Centers forMedicare& Medicaid Services assigned the Minder implant procedure to Ambulatory Payment Classification 5117 under the 2027 Hospital Outpatient Prospective Payment System rule.

Aditi Sarkar | 07 November 2026

BTC Health (ASX:BTC) Adds India to Exclusive Cardiac Device Distribution Rights

BTC Cardio signed a revised exclusive agreement with UK manufacturer Exstent, covering India alongside Australia.

Aditi Sarkar | 07 November 2026

Mayne Pharma Group (ASX:MYX) Agrees AUD 55.5 Million Divestment to Focus on US Specialty Medicines

Mayne Pharma agreed to sell all shares in Mayne Pharma International Pty Ltd for AUD 55.5 million in cash at completion, subject to customary working-capital adjustments.

Aditi Sarkar | 07 November 2026

Pacific Edge (ASX:PEB) Medicare Coverage Sets a December Start Date for Two Cxbladder Tests

The final Local Coverage Determination for urine-based biomarkers in patients with microhematuria, identified as L40378, confirms coverage for Cxbladder Triage and Triage Plus.

Aditi Sarkar | 07 November 2026

AVITA Medical (ASX:AVH) Quarterly Revenue Climbs as Operating Loss Narrows in September Period

TotalRevenuefor the three months ended 30 September 2026 was US$26.114 million, up from US$17.062 million a year earlier.

Aditi Sarkar | 07 November 2026
Support

Hi! How can we help you today?

Loading…